about
Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on AlbuminuriaRelationships between salt sensitivity of blood pressure and sympathetic nervous system activity: a short review of evidence.Impact of the renin-angiotensin system on lipid and carbohydrate metabolism.Altered renal sodium handling and risk of incident hypertension: Results of the Olivetti Heart StudyCardiovascular risk and hypertension control in Italy. Data from the 2015 World Hypertension Day.Dietary salt intake and risk of gastric cancer.The blood pressure-salt sensitivity paradigm: pathophysiologically sound yet of no practical value.Population based strategy for dietary salt intake reduction: Italian initiatives in the European framework.Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study.The Olivetti Heart Study: Predictive value of a new adiposity index on risk of hypertension, blood pressure, and subclinical organ damage.Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension.Excess dietary sodium and inadequate potassium intake by hypertensive patients in Italy: results of the MINISAL-SIIA study program.Calcium-channel blockers and sodium intake: a controlled study in patients with essential hypertension.Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men.Predictors of resistant hypertension in an unselected sample of an adult male population in Italy.Lack of association between polymorphism in the beta2-adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study.Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension.Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men.Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension.Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies.Effect of dietary sodium restriction on arterial stiffness: systematic review and meta-analysis of the randomized controlled trials.Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study.Prediction and consistency of blood pressure salt-sensitivity as assessed by a rapid volume expansion and contraction protocol. Salt-Sensitivity Study Group of the Italian Society of Hypertension.NaCl sensitivity of essential hypertensive patients is related to insulin resistance.On the pathogenetic mechanism of hypercalciuria in genetically hypertensive rats of the Milan strain.Disturbances of renal and erythrocyte calcium handling in rats of the Milan hypertensive strain.Interactions of analogs of the 1,4-dihydropyridine tiamdipine in cardiac and smooth muscle.Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.Prevalence of simple nodular goiter and Hashimoto's thyroiditis in current, previous, and never smokers in a geographical area with mild iodine deficiencyDevelopment of hypertension after correction of primary hyperparathyroidismMetabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertensionAltered extracellular calcium homoeostasis in essential hypertension: A consequence of abnormal cell calcium handlingControlled trial of long-term oral calcium supplementation in essential hypertensionComparative bioavailability of aspirin from buffered, enteric-coated and plain preparationsPlasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet functionSalicylate-aspirin interaction and thrombosis prevention trials
P50
Q28085248-CA9E5A3E-5CB5-43B9-993F-D59494134C93Q34196381-8AC675BC-1628-44CF-89ED-118650AC302AQ35741795-C705CB9A-8478-49CD-B0CB-4393EA503A8DQ36280113-B0B9F1BD-5CD7-4F33-8DE3-423E49815E0FQ36390002-73AD3371-FDDD-49C2-B68E-30C2C14A4091Q38151530-0823A3B6-E7C9-4857-A94E-962DC736D0AAQ38926853-DC5256C3-B4B4-46CA-8C9E-855F2AA23DEBQ39648217-E7677F7F-7CFD-4F03-96FC-18D23CDB582CQ39953505-D368FC5A-876A-4F87-BAE0-06C0A70D241BQ40679166-B9496B0F-7D36-4B87-9531-B48747B4B55AQ40774587-F4127DB7-2D04-4AB9-B663-5B42BBD0E96CQ42282833-CA81ED91-5342-4F1B-B87B-8A0433285DFBQ43561436-50166C4C-D889-43A2-ADD7-F2E64FA8753BQ43639120-078CC6E8-CA6C-44CF-A3E2-8C9005916183Q43748965-CD589200-A5CA-4D04-88C9-7E5C64C838F6Q43798649-B385CCCA-57BF-4FD7-AE7B-D17446E5DE39Q44900921-7E239C1D-0924-4AB4-86AC-DEF69AE5E88FQ45026030-94D5C674-B214-4815-A918-F64484BAB029Q46657751-009EBC36-DC00-40D3-B6D6-2CC5FFD0C02CQ47355323-81B73497-579F-46C2-852D-9C22AA42B882Q48043732-B6C465AC-C408-400D-9BB6-A76B0C9065E5Q48149746-0E72EF48-E348-4C36-9A67-E8DC268E825DQ50224003-7A61A8B9-0473-4896-8EE4-FF45C97A7A5DQ51221916-9B14B667-8C49-43FA-B8A8-AFCFF45A7EADQ51467928-A297B11F-5AD4-4042-8505-388C693C64AAQ51557630-2BAE7722-4778-4B26-A3F1-F97C0C31C8F9Q51571806-3F8E1502-6A38-456C-845F-B2B86DD25D77Q51618815-E2BC35BD-2FB0-41D8-B3BA-39643E4F4E2BQ51633053-A30AB68E-C7B3-49F1-BAC6-07E0D3011EE3Q53861821-45C16593-07D5-4C64-AD6B-F4D8BB0B272EQ53998695-08975147-EC12-4CEB-9B3A-F80E72FB3871Q55070146-08D9BF8E-AC3B-4565-B993-FB7ED70D8AEFQ56243398-D761C5F5-DE5A-4163-859A-FAEFD14F962AQ57368599-2984831E-DCC6-490F-A307-28CA4F740E1EQ57368616-6FB30DE1-9145-4D23-B81D-4CEC8D36ED2DQ57368645-488E63B2-6B1A-4229-A443-4A59B74E3C07Q57368656-72D94E8D-A947-4718-8BEA-EACFA442E098Q58412160-E7493CA0-2C69-4EB0-8515-9BA6BFB5AEC4Q58412221-3A00DD7E-7866-4904-AA08-8FC5C6BB55EFQ58412246-AFFAE6CB-281C-48FF-8BC8-C72CA8B81EED
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ferruccio Galletti
@ast
Ferruccio Galletti
@en
Ferruccio Galletti
@es
Ferruccio Galletti
@nl
Ferruccio Galletti
@sl
type
label
Ferruccio Galletti
@ast
Ferruccio Galletti
@en
Ferruccio Galletti
@es
Ferruccio Galletti
@nl
Ferruccio Galletti
@sl
prefLabel
Ferruccio Galletti
@ast
Ferruccio Galletti
@en
Ferruccio Galletti
@es
Ferruccio Galletti
@nl
Ferruccio Galletti
@sl
P106
P1153
7006210155
P31
P496
0000-0001-7556-0254